Is there a connection between migraines and the Mirena (levonorgestrel intrauterine device (IUD)) in women with a history of migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Connection Between Migraines and Mirena (Levonorgestrel IUD)

Mirena may actually help reduce menstrual-related migraines rather than cause them, because it is a progestin-only contraceptive that avoids estrogen withdrawal—the primary trigger for menstrual migraines—and often leads to lighter periods or amenorrhea, which can decrease hormonal migraine triggers. 1

Understanding the Migraine-Hormone Connection

The relationship between migraines and reproductive hormones is well-established:

  • 18-25% of women with migraine experience menstrual-related attacks, with migraine frequency showing clear variations over the menstrual cycle 2
  • Estrogen fluctuations, particularly estrogen withdrawal during menstruation, are the primary trigger for menstrual migraines in susceptible women 3
  • Migraine prevalence is 3-fold higher in postpubertal females compared to males, and attacks are more likely to occur in the perimenstrual period 3

Why Mirena May Be Beneficial for Migraines

Progestin-Only Formulation Avoids Estrogen Risks

  • Mirena contains only levonorgestrel (a progestin) with no estrogen component, releasing 20 micrograms per 24 hours locally into the uterus 1
  • This avoids the estrogen-withdrawal mechanism that precipitates menstrual migraines, unlike combined hormonal contraceptives that contain estrogen 1
  • Progestin-only contraceptives like Mirena are considered safer alternatives to combined hormonal contraceptives, which increase stroke risk in women with migraine 4

Reduction in Menstrual Bleeding Decreases Hormonal Triggers

  • Many women experience lighter periods or complete amenorrhea with Mirena use, which could theoretically reduce the hormonal trigger for menstrual migraines 1
  • Mirena provides therapeutic reduction in both menstrual bleeding and pain, with continuation rates of 75% or greater at one year 5, 1
  • The stabilization of hormonal fluctuations through reduced or absent menstruation may help decrease migraine frequency 1

Evidence from Progestin-Only Contraceptives

While specific data on Mirena and migraines is limited, research on oral progestin-only contraceptives provides supportive evidence:

  • A 180-day study of the progestin-only pill desogestrel showed significant reductions in migraine days (5.8 vs 3.6 days), headache intensity, and triptan use 4
  • 60% of participants achieved a clinically meaningful 30% reduction in pain, with major improvements occurring in the initial 90 days and further improvement with longer use 4
  • Quality of life improved significantly with progestin-only contraception in women with migraine 4

Clinical Decision-Making for Women with Migraines

When Mirena Is Particularly Appropriate

Consider Mirena if the patient:

  • Needs contraception AND has menstrual-related migraines 1
  • Has contraindications to estrogen-containing contraceptives 1
  • Has heavy menstrual bleeding (menorrhagia) contributing to migraine burden 1
  • Has migraine WITH aura, where combined hormonal contraceptives are absolutely contraindicated due to increased stroke risk 1

Important Safety Considerations

  • Combined hormonal contraceptives are contraindicated in women with migraine with aura due to increased stroke risk 1
  • The U.S. Medical Eligibility Criteria does not list migraine as a contraindication to levonorgestrel IUD use 6
  • Progestin-only methods like Mirena avoid estrogen-associated stroke risks, making them suitable for women with cardiovascular risk factors or migraine with aura 5

Realistic Expectations and Management

Mirena Should Not Be Sole Migraine Treatment

  • Do not rely on Mirena alone if menstrual migraines are severe and disabling—continue evidence-based acute treatments (triptans) and perimenstrual prophylaxis 1
  • First-line treatments for menstrual migraine remain perimenstrual prophylaxis with NSAIDs (naproxen) or triptans (frovatriptan or naratriptan) for 5 days, beginning 2 days before expected menstruation 1
  • Continuous combined hormonal contraceptives are recommended for pure menstrual migraine without aura, but guidelines make no specific mention of progestin-only IUDs like Mirena 1

Common Pitfalls to Avoid

  • Do not assume Mirena will worsen migraines—the progestin-only formulation without estrogen withdrawal is mechanistically different from combined hormonal contraceptives 1
  • Counsel patients that bleeding pattern changes do not correlate with contraceptive failure and that initial irregular bleeding is common but typically improves over time 5
  • If a patient reports worsening migraines after Mirena insertion, evaluate for other causes and ensure proper device positioning, but recognize this is not a typical pattern based on hormonal mechanisms 1

Bottom Line

Mirena is not only safe for women with migraines but may provide therapeutic benefit for menstrual-related migraines by eliminating estrogen withdrawal triggers and reducing menstrual bleeding. 1 It is particularly valuable for women with migraine with aura who cannot use estrogen-containing contraceptives. 1 However, it should complement, not replace, standard migraine treatments for women with severe disease. 1

References

1
Guideline

Mirena IUD and Menstrual Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

Levonorgestrel Intrauterine Device (IUD) Contraception and Therapeutic Benefits

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

6
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What should a patient with a history of migraines, who recently stopped hormone replacement therapy (HRT) with testosterone and estrogen, do after experiencing an episode of lightheadedness, tingling, and numbness all over their body while taking medication for migraines?
Can estradiol (estrogen) patches or cream be used to treat migraines triggered by hormonal fluctuations?
What is the best contraceptive option for a 50-year-old woman with migraines, a Body Mass Index (BMI) of 25, Polycystic Ovary Syndrome (PCOS), and acne?
Is Divigel (estradiol) low-dose gel and Sumatriptan (Imitrex) a suitable treatment for a 47-year-old perimenopausal female with anxiety-driven hypertension, recent onset migraines, and elevated triglycerides, who is currently taking compounded testosterone and progesterone therapy, Armour Thyroid (desiccated thyroid), and has a history of normal electrocardiogram (EKG) and echocardiogram?
Is a 45-year-old female with a history of hysterectomy (surgical removal of the uterus) with bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes), and migraines with auras, a suitable candidate for hormone replacement therapy (HRT)?
What does a follicle-stimulating hormone (FSH) level of 10, within the normal range, indicate for a female of reproductive age with a normal count regarding fertility and reproductive health?
What are the management and prevention strategies for a patient with Lynch syndrome, a genetic disorder that increases the risk of colorectal and other cancers?
What is the role of dosulepin (tricyclic antidepressant) in managing osteoarthritis, particularly in older adults with potential comorbid conditions and a history of depression or chronic pain?
What alternative phosphodiesterase type 5 (PDE5) inhibitor, such as Avanafil (Avanafil), Sildenafil (Sildenafil), or Vardenafil (Vardenafil), can be used for a patient with erectile dysfunction (ED) who is experiencing severe headaches while taking Tadalafil (Tadalafil) 5mg up to 4 tablets once daily?
What is the appropriate management for an adult patient with an infundibular origin of the left posterior communicating artery (PCOM), considering the risk of cerebral aneurysm formation and cerebrovascular events?
What is the best next step for a 19-year-old patient with bilateral hand itching and rashes, likely due to irritant contact dermatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question